Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 135

Results For "RAT"

10026 News Found

GSK launches $124-a-share takeover bid for cancer biotech Nuvalent
News | June 26, 2026

GSK launches $124-a-share takeover bid for cancer biotech Nuvalent

The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent


Fermenta Biotech ranked among India's top 10 mid-size workplaces by Great Place To Work
News | June 26, 2026

Fermenta Biotech ranked among India's top 10 mid-size workplaces by Great Place To Work

Company secures 7th position nationwide in India's Great Mid-size Workplaces 2026, reinforcing its people-first culture as it marks 75 years of excellence


Zydus Lifesciences expands Sri Lanka presence with USD 20 million manufacturing JV
News | June 26, 2026

Zydus Lifesciences expands Sri Lanka presence with USD 20 million manufacturing JV

Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience


AIIMS, ALSCAS mark global ALS Awareness Day
Hospitals | June 26, 2026

AIIMS, ALSCAS mark global ALS Awareness Day

Experts announce upcoming Amyotrophic lateral sclerosis (ALS) studies, advocate early diagnosis, comprehensive care, and stronger support systems for patients and caregivers


Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal
Biopharma | June 26, 2026

Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal

Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing


SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform
Startup | June 25, 2026

SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform

The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets


Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal
News | June 25, 2026

Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal

Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties


Experts call for uniform quality standards for blood and blood components
Policy | June 25, 2026

Experts call for uniform quality standards for blood and blood components

National conference brings together 160+ experts from six states to advance blood quality and safety standards


AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
Digitisation | June 25, 2026

AI moves from experimentation to enterprise tool across pharma value chain: GlobalData

34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases


Mankind Pharma launches nationwide preventive oncology initiative to reach one million women
Healthcare | June 25, 2026

Mankind Pharma launches nationwide preventive oncology initiative to reach one million women

Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities